Relmada Therapeutics, Inc. (NASDAQ:RLMD) Q4 2025 Earnings Call Transcript March 19, 2026 Relmada Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.27 EPS, expectations were ...

Shenouda With me on today's call are Relmada Therapeutics, Inc.'s CEO, Dr. Sergio Traversa, who will briefly provide a summary of recent business highlights; Dr. Raj S. Pruthi, Relmada Therapeutics, ...

Today’s financial mood highlights cautious optimism, with markets weighing inflation trends, interest-rate expectations and shifting consumer behaviour. Each sign may notice subtle shifts in ...

Lesley Cordero discusses platform engineering as a practice for driving sociotechnical change and organizational ...

Digital platform group faces volatility despite strong revenue expansion trends Market narrative points to valuation gap tied to margin trajectory changes Core segments Shopee and Garena remain ...

BlackRock MuniHoldings New Jersey Quality Fund is part of the financial services sector, with a portfolio centred on ...

Hello, everyone, and welcome to ASSA ABLOY Sustainability seminar in 2026. My name is Bjorn Tibell, and I'm heading Investor Relations. Before we dig into today's agenda, a word about safety, please ...

X-Humanoid, a Chinese robotics developer, says it connected its “Embodied Tien Kung” humanoid robot to a low-Earth-orbit satellite and used that link to carry out an autonomous delivery task. The ...

For the year ended December 31, 2025, wholesale channel net sales decreased by 5.4% (1) year-over-year, driven by a 7.1% (1) reduction in net sales to traditional brick-and-mortar wholesale customers ...

Temple Bar Investment Trust Plc - Annual Financial Report for the year ended 31 December 2025 PR Newswire LONDON, United Kingdom, March 20 Temple ...

Long-term lithium therapy remains the most effective maintenance treatment for bipolar disorder, yet it poses a significant risk of progressive renal impairment in a subset of patients. Early ...